Veliparib (CAS 912444-00-9)
« Back to Anti-Cancer API
Veliparib
CAS No. 912444-00-9
维利帕尼
Chemical structure
| CAS No. | 912444-00-9 |
|---|---|
| Synonyms | 2-[(2R)-2-Methyl-2-pyrrolidinyl]-1H-benzimidazole-7-carboxamide |
| Category | Anti-Cancer API / Anti-Cancer |
| Assay / Purity | 99% |
| Molecular Formula | C13H16N4O |
| Molecular Weight | 244.29 |
| Melting Point | — |
| Boiling Point | — |
| Density | — |
| Flash Point | — |
| Appearance | Off-white to white solid powder |
Application and positioning
Veliparib is an orally available PARP-1/2 inhibitor that potentiates DNA-damaging chemotherapy and radiotherapy. It is an investigational agent studied in triple-negative breast cancer, non-small cell lung cancer and ovarian cancer. Laurand supplies it from audited Chinese production partners for pharmaceutical manufacturing and process development.
Quality and documentation
- Batch-specific Certificate of Analysis issued by the manufacturing site
- SDS/MSDS and specification sheet available on request
- Residual solvents and elemental impurities statements discussed per project
- For pharmaceutical manufacturing and R&D use only — not for direct administration
Packaging and handling
- Packed in double polyethylene-lined fibre drums; pack size confirmed at quotation
- Small quantities in sealed aluminium foil bags
- Palletised for air and sea freight; store dry, ventilated and protected from light
Related products
- Vemurafenib (CAS 918504-65-1)
- Abemaciclib, LY2835219 (CAS 1231929-97-7)
- Acalabrutinib, ACP-196 (CAS 1420477-60-6)
- Afatinib Dimaleate (CAS 850140-73-7)
Specifications shown are indicative. The final specification and documentation package are confirmed with the quotation.
Interested in this product?
Contact us for price, COA, MSDS and lead time — custom synthesis available.
Request a QuoteReference: CAS 912444-00-9 · PubChem CID 11960529